Next Article in Journal
How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Previous Article in Journal
Drug–Phospholipid Co-Amorphous Formulations: The Role of Preparation Methods and Phospholipid Selection
Previous Article in Special Issue
Achieving the Optimal AgO Concentrations to Modulate the Anti-Trypanosoma cruzi Activity of Ag-ZnO/AgO Nanocomposites: In Vivo Investigations
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(12), 1603; https://doi.org/10.3390/pharmaceutics16121603
Action Date Notes Link
article xml file uploaded 16 December 2024 15:36 CET Original file -
article xml uploaded. 16 December 2024 15:36 CET Update https://www.mdpi.com/1999-4923/16/12/1603/xml
article pdf uploaded. 16 December 2024 15:36 CET Version of Record https://www.mdpi.com/1999-4923/16/12/1603/pdf
article supplementary file uploaded. 16 December 2024 15:36 CET - https://www.mdpi.com/1999-4923/16/12/1603#supplementary
article html file updated 16 December 2024 15:39 CET Original file https://www.mdpi.com/1999-4923/16/12/1603/html
Back to TopTop